SkinBioTherapeutics (SBTX) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Jan 2021 04:35 PM
RNS
Price Monitoring Extension
30 Dec 2020 11:05 AM
RNS
Second Price Monitoring Extn
30 Dec 2020 11:00 AM
RNS
Price Monitoring Extension
29 Dec 2020 02:06 PM
RNS
Second Price Monitoring Extn
29 Dec 2020 02:01 PM
RNS
Price Monitoring Extension
29 Dec 2020 12:59 PM
RNS
Result of AGM
04 Dec 2020 04:44 PM
RNS
Director Dealing
04 Dec 2020 07:00 AM
RNS
Final Results
02 Dec 2020 11:16 AM
RNS
Notice of Results
02 Nov 2020 04:15 PM
RNS
Holding(s) in Company
02 Nov 2020 03:49 PM
RNS
Holding(s) in Company
30 Oct 2020 12:23 PM
RNS
Result of General Meeting and Open Offer
14 Oct 2020 07:00 AM
RNS
Placing and Open Offer
18 Sep 2020 04:48 PM
RNS
Grant of Options
08 Sep 2020 07:19 AM
RNS
Appointment of Senior Medical Advisor
31 Jul 2020 07:00 AM
RNS
Product Development Progress
07 Jul 2020 07:00 AM
RNS
Business Update
26 Jun 2020 07:00 AM
RNS
Change of Adviser
23 Jun 2020 04:29 PM
RNS
Holding(s) in Company
01 Jun 2020 03:45 PM
RNS
Holding(s) in Company
17 Apr 2020 04:24 PM
RNS
Holding(s) in Company
17 Mar 2020 04:42 PM
RNS
Second Price Monitoring Extn
17 Mar 2020 04:38 PM
RNS
Price Monitoring Extension
03 Mar 2020 07:00 AM
RNS
Half Year Results
19 Feb 2020 07:00 AM
RNS
Agreement signed with Winclove Probiotics B.V.
19 Feb 2020 07:00 AM
RNS
Agreement signed with Winclove Probiotics B.V.
19 Dec 2019 11:47 AM
RNS
Result of AGM
26 Nov 2019 08:50 AM
RNS
Notice of AGM
26 Nov 2019 07:00 AM
RNS
Final Results
20 Nov 2019 07:00 AM
RNS
Commercial Agreement
06 Nov 2019 10:38 AM
RNS
Holding(s) in Company
28 Aug 2019 02:05 PM
RNS
Second Price Monitoring Extn
28 Aug 2019 02:00 PM
RNS
Price Monitoring Extension
28 Aug 2019 07:00 AM
RNS
Holding(s) in Company
04 Jul 2019 07:00 AM
RNS
Business Update and Board Changes
18 Apr 2019 07:00 AM
RNS
Director Appointment
16 Apr 2019 07:00 AM
RNS
Director/PDMR Shareholding
08 Apr 2019 07:00 AM
RNS
SkinBiotix shows efficacy in first human study
29 Mar 2019 07:00 AM
RNS
CEO Designate Appointment
18 Feb 2019 07:00 AM
RNS
Issue of Equity
14 Feb 2019 07:00 AM
RNS
Half year results
01 Feb 2019 03:30 PM
RNS
Appointment of Joint Broker
31 Jan 2019 08:35 AM
RNS
Update on human study and IP portfolio extension
31 Jan 2019 07:00 AM
RNS
Update on human studies & IP portfolio extension
20 Nov 2018 07:00 AM
RNS
Commencement of final phase of human studies
19 Nov 2018 12:30 PM
RNS
Result of AGM
07 Nov 2018 07:00 AM
RNS
SkinBiotix® generates positive data in human study
25 Oct 2018 07:00 AM
RNS
Full year results
19 Sep 2018 07:00 AM
RNS
Human study commenced
18 Sep 2018 02:05 PM
RNS
Second Price Monitoring Extn

SkinBioTherapeutics is a life science company that develops technologies to improve health by harnessing the human microbiome.

SkinBioTherapeutics is based in Newcastle upon Tyne, United Kingdom.

SkinBioTherapeutics is listed in London under the ticker SBTX.

SBTX share price listed at 16p in 2017.

UK 100

Latest directors dealings